Clinical trial NCT06582030: Stop Addiction Stigma
Official title: Stop Addiction Stigma Training Workshop With Case Vignettes to Decrease Stigmatizing Attitudes Toward People With Substance Abuse Disorders
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Lead sponsor: Ohio State University Comprehensive Cancer Center
Sponsor class: OTHER
First posted: 2024-09-03
Enrollment: 93
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward individuals with substance abuse disorders. Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers. Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care. Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction, reduce the stigma toward addiction and improve the quality of health care.

Detailed description: PRIMARY OBJECTIVE:

I. To describe the impact of SAS training on participants' responses to people with a substance impairment.

SECONDARY OBJECTIVES:

I. To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel.

II. To explore the maintainability of responses over time. III. To explore relationships between language and stigmatizing attitudes.

OUTLINE: Participants are randomized to 1 of 6 group case vignettes.

GROUP A (CHRONICALLY RELAPSING BRAIN DISEASE): Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study.

GROUP B (BRAIN DISEASE): Participants view the brain disease vignette and attend a SAS workshop on study.

GROUP C (DISEASE): Participants view the disease vignette and attend a SAS workshop on study.

GROUP D (ILLNESS): Participants view the illness vignette and attend a SAS workshop on study.

GROUP E (DISORDER): Participants view the disorder vignette and attend a SAS workshop on study.

GROUP F (PROBLEM): Participants view the problem vignette and attend a SAS workshop on study.

Eligibility criteria: Inclusion Criteria:

* Employee of Ohio State University Wexner Medical Center (OSUWMC)
* Age ≥ 18 years
* Participants must be able to read and comprehend survey items

Primary outcomes:
measure: Stigmatizing attitudes
timeFrame: Before, immediately after and 8 weeks after the session
Secondary outcomes:
measure: Attendance rate
timeFrame: At 90 minute session.
measure: Response to post-workshop evaluations
timeFrame: Before, immediately following and 8 weeks after the session.
Other outcomes:
Locations:
city: Columbus
country: United States
facility: Ohio State University Comprehensive Cancer Center
state: Ohio
Study officials:
affiliation: Ohio State University Comprehensive Cancer Center
name: Gretchen A Mcnally, PhD, APRN-CNP
role: PRINCIPAL_INVESTIGATOR
References: